Traduction de «to point out which » (Néerlandais → Français) :

They aim to highlight the impact of reports on suicides, to provide reliable sources of information, to give suggestions about how to report on suicides both in general and in specific circumstances and to point out which pitfalls to avoid when reporting on suicide.
Ces indications ont pour but de mettre en évidence l’impact des reportages sur le suicide, d’indiquer les sources d’information fiables, de suggérer comment rapporter le suicide aussi bien dans des circonstances générales que spécifiques, et de préciser les pièges à éviter dans un reportage sur le suicide.

pointed out that the exceptional tax alone, which brought in 4,813,933 euros, represented 38% of total taxes collected (see graph).
pointed out that the exceptional tax alone, which brought in 4,813,933 euros, represented 38% of total taxes collected (see graph).

On the other hand, the federal Minister of Public Health points out that, until harmonised provisions have been introduced at the European level, caffeine falls under the food additives legislation in Belgium and that this harmonisation will be carried out in a different context than the food additives legislation.
Par ailleurs, le Ministre Fédéral de la Santé Publique précise clairement que la caféine relève en Belgique de la législation sur les additifs jusqu’à ce qu’une harmonisation soit opérée à l’échelon européen et que cette harmonisation se fera dans un autre cadre que celui de la législation sur les additifs.

However, it should be pointed out that some eating disorders (anorexia) can be linked with an increased risk of committing suicide.
Notons cependant que certains troubles alimentaires (anorexie) peuvent être associés à une augmentation du risque suicidaire.

It should be pointed out that the person faced with the problem always considers the sort of solution that he/she can find in suicide to be an adequate one.
Il faut remarquer que cette solution qu’est le suicide est toujours adéquate pour la personne qui vit ce problème.

Experts point out that such an intake can cause temporary behaviour changes, such as agitation, irritability, nervousness or anxiety, in short, effects that typically accompany caffeine consumption (Nawrot et al., 2003).
Selon ces experts, un tel apport peut causer des modifications comportementales transitoires telles de l’agitation, de l’irritabilité, de la nervosité ou de l’anxiété, effets typiquement liés à une consommation de caféine (Nawrot et al., 2003).

Finally, the SCF pointed out that the possible interactions between caffeine, taurine and alcohol had not been correctly studied and that new research into the interactions between these ingredients was necessary in humans, especially in the event of physical effort accompanied by a considerable loss of water through sweating (SCF, 1999).
Enfin, le SCF a souligné que les interactions possibles entre ces constituants n’ont pas été bien étudiées et que les interactions entre la caféine, la taurine et l’alcool nécessitaient de nouvelles investigations chez l’homme, particulièrement lors d’un exercice physique associé à une intense perte d’eau par la sueur (SCF, 1999).

This report also took into account further developments (SCF, 2003) Here the SCF points out that it does not change its view on caffeine.
Dans celui-ci, le SCF indique qu’il ne modifie pas son opinion sur la caféine.

There is a set of minutes of “A points”, which may be consulted via intranet by all FAMHP employees, and one of the “B points”, which deals with more confidential and/or personal topics and is for that reason, only circulated to the members of the executive board.
There is a set of minutes of “A points”, which may be consulted via intranet by all FAMHP employees, and one of the “B points”, which deals with more confidential and/or personal topics and is for that reason, only circulated to the members of the executive board.

1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines
1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines